Xenon Pharmaceuticals Inc XENE
$36.94
-2.94%
at last close
Market Cap$3.58 billion
P/E Ratio—
Div Yield—
Volume2.43M
52-Week Range
$35.60$72.66
Analyst Ratings
- Consensus
- Buy — 9 Buy · 1 Hold · 0 Sell (10 analysts)
- Avg. Price Target
- $65.60 (+77.6% upside)
Key Stats
- Today's Range
- $36.48 – $38.26
- 50-Day Range
- $36.07 – $69.58
- 52-Week Range
- $35.60 – $72.66
- Volume
- 2.43 million shs
- Average Volume
- 1.66 million shs
- Market Cap
- $3.58 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.15%
- Days to Cover
- 1.11
About Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Related Stocks
Compare head-to-head: XENE vs LLY·XENE vs JNJ·XENE vs ABBV·XENE vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.